Want to see MMS full AI Analyst Report?
MMS Stock Chart & Stats
$59.54
$2.26(3.94%)
At close: 4:00 PM EDT
$59.54
$2.26(3.94%)
Day’s Range― - ―
52-Week Range$51.04 - $100.00
Previous CloseN/A
Volume505.22K
Average Volume (3M)728.96K
Market Cap
$3.21B
Enterprise Value$4.43B
Total Cash (Recent Filing)$56.95M
Total Debt (Recent Filing)$1.73B
Price to Earnings (P/E)9.0
Beta0.34
Next Earnings
Nov 19, 2026EPS Estimate
1.85Next Dividend Ex-DateN/A
Dividend Yield2.11%
Share Statistics
EPS (TTM)6.82
Shares Outstanding52,357,760
10 Day Avg. Volume743,995
30 Day Avg. Volume728,960
Financial Highlights & Ratios
PEG Ratio1.56
Price to Book (P/B)3.13
Price to Sales (P/S)0.97
P/FCF Ratio14.33
Enterprise Value/Market Cap1.38
Enterprise Value/Revenue0.84
Enterprise Value/Gross Profit3.46
Enterprise Value/Ebitda6.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.36
Revenue Forecast (FY)$5.38B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistently positive free cash flow with conversion near 90% of net income indicates strong earnings quality and internally generated funding. This supports investment, debt management, and shareholder returns while reducing reliance on external capital across the next several quarters.
Large Growth PipelineThe substantial pipeline and booked awards provide a meaningful base for future contract activity, especially because more than half of the pipeline represents new work. Successful conversion could diversify revenue sources and support growth beyond current contract timing pressures.
Strategic Defense Technology ExpansionThe proposed Agile Defense acquisition would broaden Maximus into cybersecurity, AI, and mission-critical defense technology, areas described as higher-growth federal markets. Combining specialized talent with existing delivery platforms could strengthen capabilities and expand long-term federal positioning.
Bears Say
Revenue ContractionA TTM revenue decline signals that profitability improvements have not yet translated into sustained top-line expansion. If contract awards, renewals, or program timing remain pressured, weaker scale could limit operating leverage and make future growth more dependent on new wins.
Weak Contract ConversionBook-to-bill below one indicates awards are not currently replacing delivered work at a sufficient pace, creating a risk to future revenue visibility. Procurement delays and protests may also defer pipeline conversion, extending the period before new contracts contribute materially.
Elevated LeverageHigher debt and net leverage reduce financial flexibility even though leverage remains within management's stated target range. Additional interest obligations can constrain capital allocation and leave less capacity to absorb contract delays, working-capital volatility, or acquisition-related spending.
Maximus News
MMS FAQ
What was Maximus’s price range in the past 12 months?
Maximus lowest stock price was $51.04 and its highest was $100.00 in the past 12 months.
What is Maximus’s market cap?
Maximus’s market cap is $3.21B.
When is Maximus’s upcoming earnings report date?
Maximus’s upcoming earnings report date is Nov 19, 2026 which is in 29 days.
How were Maximus’s earnings last quarter?
Maximus released its earnings results on Aug 06, 2026. The company reported $2.22 earnings per share for the quarter, beating the consensus estimate of $2.205 by $0.015.
Is Maximus overvalued?
According to Wall Street analysts Maximus’s price is currently Overvalued.
Does Maximus pay dividends?
Maximus pays a Quarterly dividend of $0.33 which represents an annual dividend yield of 2.11%. See more information on Maximus dividends here
What is Maximus’s EPS estimate?
Maximus’s EPS estimate is 1.85.
How many shares outstanding does Maximus have?
Maximus has 52,357,760 shares outstanding.
What happened to Maximus’s price movement after its last earnings report?
Maximus reported an EPS of $2.22 in its last earnings report, beating expectations of $2.205. Following the earnings report the stock price went down -7.633%.
Which hedge fund is a major shareholder of Maximus?
Currently, no hedge funds are holding shares in MMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Maximus Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MMS Sentiment 67%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Increased
By 333.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.42%
12-Months-Change
Fundamentals
Return on Equity
21.72%
Trailing 12-Months
Asset Growth
-2.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Maximus
Maximus, Inc. specializes in delivering business process services (BPS) tailored for governmental health and human welfare initiatives. Its operations are structured into three main divisions: U.S. Services, U.S. Federal Services, and International Services. The U.S. Services division delivers a wide array of BPS solutions to state and local government programs across the United States. These offerings encompass program administration, handling appeals and evaluations, and providing specialized consulting. Key programs supported include the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, and child support initiatives, alongside Preadmission Screening and Resident Reviews and Independent Developmental Disability assessments. Furthermore, this segment facilitates program eligibility and enrollment, operates centralized multilingual contact centers with multichannel and digital self-service capabilities, offers application assistance and impartial health plan selection guidance, and conducts outreach, education, eligibility determination, enrollment, and redetermination for beneficiaries. It also performs person-centered independent assessments for disability, long-term illness, and other health conditions, complemented by targeted consulting services. The U.S. Federal Services segment focuses on providing critical support to federal government agencies. Its services include establishing and managing centralized citizen engagement centers, overseeing document and record management, offering case management and direct citizen support, and delivering consumer education. This division also handles independent medical reviews, appeals for worker's compensation benefits, Medicare and Medicaid appeals, and eligibility appeals for the federal marketplace. Additionally, it contributes to the modernization of systems and IT infrastructure, provides operational support for infrastructure, offers software development, operations, and management, and specializes in data analytics. Internationally, the company's "Outside the U.S." segment delivers BPS offerings to both governmental bodies and commercial enterprises. These services include health and disability evaluations, the administration of employment programs, and various other services aimed at assisting job seekers. Established in 1975, Maximus, Inc. maintains its corporate headquarters in Tysons, Virginia.
MMS Company Deck
MMS Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a generally constructive operational and strategic picture — Q3 revenue was in line with expectations, margins improved year-over-year, a large $50.4B pipeline and $1.25B of signed awards support medium/long-term growth, AI adoption is delivering measurable margin benefits, and collections momentum has begun to relieve working capital stress. However, notable near-term headwinds include a customer-directed pause of VA MDE incentives that reduced FY26 EPS guidance by ~$0.35, elevated DSO and a Q3 free cash flow outflow, a slowed procurement environment with a trailing book-to-bill of ~0.5x, and modest profitability in Outside the U.S. Taken together, the company appears to be navigating temporary timing and contract-driven challenges while maintaining margin progress, a sizable pipeline, disciplined capital allocation, and strategic investments that support growth into FY2027.View all MMS earnings summariesTechnical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
2.01% Insiders
36.78% Mutual Funds
4.53% Other Institutional Investors
23.59% Public Companies and
Individual Investors







